trending Market Intelligence /marketintelligence/en/news-insights/trending/pwv4prfhszpzhmmojuqaqa2 content esgSubNav
In This List

Amedica closes $15M units offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Amedica closes $15M units offering

Amedica Corp. closed its underwritten public offering of units, priced at $1,000 apiece, with gross proceeds of $15 million.

Each unit comprised of one series B convertible preferred share and warrants to buy up to 758 common shares.

The warrants are initially exercisable at $1.60 per share and expire five years from the issue date.

Maxim Group LLC served as the sole book-running manager for the offering.

Salt Lake City, Utah-based Amedica is a commercial-stage biomaterial company, which develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the U.S. Europe, and South America.